Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy


Senes M., Erbay A. R., Yilmaz F. M., Topkaya B. C., Zengi U., Dogan M., ...More

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol.46, no.3, pp.382-386, 2008 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 3
  • Publication Date: 2008
  • Doi Number: 10.1515/cclm.2008.061
  • Journal Name: CLINICAL CHEMISTRY AND LABORATORY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.382-386
  • Keywords: antioxidants, cardiomyopathy, coenzyme Q10, C-reactive protein, heart failure, oxidative stress, CONGESTIVE-HEART-FAILURE, INCREASED OXIDATIVE STRESS, COA REDUCTASE INHIBITORS, CORONARY-ARTERY DISEASE, PROGNOSTIC VALUE, PLASMA, RADICALS, GLUTATHIONE, SUPEROXIDE, MARKER
  • Lokman Hekim University Affiliated: No

Abstract

Background: Cardiomyopathy (CMP) is a common debilitating illness, associated with a high mortality and poor quality of life. There is extensive evidence from in vitro and animal experiments that CMP is a state of increased oxidative stress. Coenzyme Q10 (CoQ10) and high-sensitivity C-reactive protein (hs-CRP) are important markers to evaluate the oxidative stress and inflammatory status of patients with CMP.